AP

European committee: Regulators should deny Merck’s Lagevrio

Feb 24, 2023, 6:56 AM | Updated: 8:48 am

A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators.

A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the European Union should be refused.

A statement from the agency says a committee that has been reviewing Merck’s application for more than a year concluded that the drug’s clinical benefit could not be demonstrated.

Merck said Friday that it plans to appeal the recommendation, which came from the Committee for Medicinal Products for Human Use.

The drugmaker noted that more than two dozen countries have already approved or authorized the pill, including the United States. More than 4 million people have been treated with Lagevrio.

The United Kingdom became the first country in the world to authorize the drug in November 2021.

Merck said in a statement that it remains confident that the anti-viral pill “has an important role to play in the COVID 19 treatment landscape.”

Lagevrio and Pfizer’s pill treatment, Paxlovid, hit the U.S. market more than a year ago. They offer an easier way than IV medicines to treat patients with early COVID-19 symptoms who are at risk of serious illness.

Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. U.S. regulators have said it should be used cautiously.

The U.S. Food and Drug Administration authorized the treatment in late 2021 with restrictions. It cannot be used on patients under age 18. It also isn’t recommended for pregnant women because of the potential for birth defects.

The agency also has said Merck’s drug should be considered for patients “for whom alternative COVID-19 treatment options authorized by the FDA are not accessible or clinically appropriate.”

The European Medicines Agency said Merck submitted results from a study involving more than 1,400 unvaccinated adult patients. It also provided data from other studies and real-world use.

The agency said in a statement that it wasn’t possible to conclude that Lagevrio reduces the risk of hospitalization or death or shortens recovery time or illness in adults at risk of severe complications.

The FDA has said the drug is effective against the virus, but its advisory panel only narrowly endorsed the treatment. The FDA authorized it in December 2021.

Lagevrio brought in about $5.7 billion in sales last year for Merck & Co. Inc., which is based in Rahway, New Jersey. Merck makes the treatment with Ridgeback Biotherapeutics.

For 2023, Merck forecasts about $1 billion in Lagevrio sales.

___

Follow Tom Murphy on Twitter: @thpmurphy

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

A Boeing 737 Max suffered damage to parts of the plane's structure after it went into a “Dutch ro...

Associated Press

Plane that did ‘Dutch roll’ on flight from Phoenix suffered structural damage, investigators say

A Boeing 737 Max suffered damage to parts of the plane's structure after it went into a “Dutch roll” during a flight from Phoenix last month.

3 days ago

This photo provided by Randy Shannon shows Mooney Falls on the Havasupai reservation outside the vi...

Associated Press

Dozens report illness after trips to waterfalls near Grand Canyon

Dozens of hikers say they fell ill during trips to a popular Arizona tourist destination that features towering blue-green waterfalls deep in a gorge neighboring Grand Canyon National Park.

4 days ago

Mugshot of Rudy Giuliani, who was processed Monday, June 10, 2024, in the Arizona fake electors cas...

Associated Press

Rudy Giuliani posts $10K cash bond after being processed in Arizona fake electors case

Rudy Giuliani, a former New York City mayor and Donald Trump attorney, was processed Monday in the Arizona fake electors case.

6 days ago

FILE - White House former chief of staff Mark Meadows speaks with reporters at the White House, Wed...

Associated Press

Former Trump chief of staff Mark Meadows pleads not guilty in Arizona fake elector case

Former Donald Trump presidential chief of staff Mark Meadows and Trump 2020 Election Day operations director Michael Roman pleaded not guilty Friday in Phoenix to nine felony charges for their roles in an effort to overturn Trump's Arizona election loss to Joe Biden.

10 days ago

deadly heat wave last summer...

Associated Press

After a deadly heat wave last summer, metro Phoenix is changing tactics

Fresh memories of the deadly heat wave last summer have led Arizona authorities to launch new tactics ahead of summer 2024.

20 days ago

A Yuma man has been arrested for allegedly starting a wildfire in a national wildlife preserve near...

Associated Press

Man accused of starting wildfire in national wildlife preserve in Yuma

A Yuma man has been arrested for allegedly starting a wildfire in a national wildlife preserve near the California border.

21 days ago

Sponsored Articles

...

Day & Night Air Conditioning, Heating and Plumbing

Beat the heat, ensure your AC unit is summer-ready

With temperatures starting to rise across the Valley, now is a great time to be sure your AC unit is ready to withstand the sweltering summer heat.

...

DESERT INSTITUTE FOR SPINE CARE

Desert Institute for Spine Care is the place for weekend warriors to fix their back pain

Spring has sprung and nothing is better than March in Arizona. The temperatures are perfect and with the beautiful weather, Arizona has become a hotbed for hikers, runners, golfers, pickleball players and all types of weekend warriors.

...

DISC Desert Institute for Spine Care

Sciatica pain is treatable but surgery may be required

Sciatica pain is one of the most common ailments a person can face, and if not taken seriously, it could become one of the most harmful.

European committee: Regulators should deny Merck’s Lagevrio